United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar OklaBoston (67.12) Submitted: 12/23/2012 10:55:34 AM : Outperform Start Price: $52.19 UTHR Score: +66.99

CEO open market buying, primarily. Separate blocks, 3000 shares each, last week.

Featured Broker Partners


Advertisement